Chongqing BDSyn Biotech Co., Ltd,

Exhibitor

Chongqing BDSyn Biotechnology Co., Ltd.

BDSyn Biotech is an innovative biotechnology company specializing in the research, development, and production of vaccine adjuvants. With globally leading adjuvant industrialization technologies, the company has successfully developed structurally defined QS-21 Api and monophosphoryl lipid A (MPL) series products. It supplies both traditional adjuvants (e.g., aluminum hydroxide) and novel adjuvant systems (e.g., BDS01–BDS08). Additionally, BDSyn provides comprehensive technical and product services, including adjuvant raw materials, formulated adjuvant preparations, and adjuvant screening. Committed to technological innovation, BDSyn is dedicated to delivering high-performance and safe adjuvant solutions for global vaccine manufacturers.



website

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK

 

Isla Sutherland
Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.